GEODE CAPITAL MANAGEMENT, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in AMRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$88,963,861
+$32,456,485 QoQ
Shares Held
5,139,449
+13.1% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. AMRX ranks #12 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in AMRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,963,861 | 5,139,449 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $56,507,376 | 4,546,048 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,230,579 | 3,986,554 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $40,386,676 | 4,034,633 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $30,411,077 | 3,759,095 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $32,056,943 | 3,825,411 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $30,200,599 | 3,813,207 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $31,505,102 | 3,786,671 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $21,644,196 | 3,408,535 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $16,804,683 | 2,773,050 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,806,229 | 2,439,247 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,791,286 | 2,320,210 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,804,472 | 2,194,991 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,607,254 | 1,875,723 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,641,895 | 1,830,098 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,601,979 | 1,783,158 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,506,386 | 1,731,568 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,141,838 | 1,712,671 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,435,463 | 1,761,057 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,650,794 | 1,619,999 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,639,475 | 1,882,710 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,260,155 | 1,821,717 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,489,247 | 1,638,785 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,206,125 | 1,599,517 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,737,836 | 1,625,596 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,938,835 | 1,706,562 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||